NCT00152139
Stem Cell Transplantation for Patients With Hematologic Malignancies No drug interventions treatment 3 completed NCT04678869
CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia) No drug interventions supportive_care Not Available recruiting NCT02333058
Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies treatment 2 completed NCT02647190
Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older No drug interventions treatment 1 withdrawn NCT03067584
Genetic Study of Familial Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00495079
Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT02269579
Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment No drug interventions treatment 2 withdrawn NCT00840853
Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT treatment 1 active_not_recruiting NCT01439347
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL treatment 3 terminated NCT01351545
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) No drug interventions Not Available Not Available recruiting NCT01885897
IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT treatment 1 / 2 completed NCT03590171
International Study for Treatment of High Risk Childhood Relapsed ALL 2010 treatment 2 recruiting NCT04029688
A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors treatment 1 / 2 completed NCT03327285
C-CAR011 Treatment in Subjects With ALL After HSCT No drug interventions treatment Not Available unknown_status NCT00672152
A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation No drug interventions treatment 1 terminated NCT01758042
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders No drug interventions treatment Not Available recruiting NCT02730299
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS treatment 3 active_not_recruiting NCT00145613
Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies No drug interventions treatment 2 completed NCT06182163
Reduce Sedentary Time in Acute Lymphoblastic Leukemia No drug interventions supportive_care Not Available recruiting NCT06392763
Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data No drug interventions Not Available Not Available completed NCT02238925
An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients No drug interventions treatment 2 completed NCT01816230
Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM treatment 1 / 2 completed NCT02259348
Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation treatment 2 terminated NCT03236857
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies treatment 1 completed NCT01221857
Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies treatment 1 / 2 completed NCT03229876
Safety and Efficacy Evaluation of CD19-UCART No drug interventions treatment Not Available suspended NCT02046694
A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL treatment 0 completed NCT02200380
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs treatment 2 terminated NCT01802814
International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010 treatment 3 completed NCT01735955
Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study treatment 4 completed NCT01527838
Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit No drug interventions treatment 1 completed NCT05291390
Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML) treatment 2 unknown_status NCT01050764
Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells treatment 1 / 2 terminated NCT02303821
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia treatment 1 completed NCT05884333
Cord Blood Transplant in Adults With Blood Cancers No drug interventions treatment 2 recruiting NCT03849651
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies treatment 2 active_not_recruiting NCT02894645
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study treatment 4 unknown_status NCT02212561
Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome treatment 1 completed NCT02226861
Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation prevention 1 completed NCT01282593
Potential Role of CD9 and Implication of Motility Process in Pathogenesis of TEL/ALM1-positive ALL Relapses (LAL TEL/ALM1 and CD9). No drug interventions other Not Available completed NCT01660607
Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell No drug interventions treatment 1 / 2 completed NCT02790515
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation treatment 2 recruiting NCT02061800
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant treatment 1 / 2 active_not_recruiting NCT03601442
CTL019 Out of Specification MAP for ALL or DLBCL Patients Not Available Not Available available NCT04929899
Bright Ideas - CIN Feasibility Study No drug interventions supportive_care Not Available recruiting NCT03740334
Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL treatment 1 active_not_recruiting NCT03181126
A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma treatment 1 completed NCT03123029
Expanded Access to Venetoclax Not Available Not Available available NCT03260101
Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study No drug interventions Not Available Not Available unknown_status NCT05349201
CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI) No drug interventions Not Available Not Available completed NCT05366569
Bio-CAR-T BS Study No drug interventions Not Available Not Available recruiting NCT04559555
MAP to Provide Access to Nilotinib, for Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available no_longer_available NCT01305655
Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL No drug interventions treatment 3 completed NCT02338050
Moxetumomab Pasudotox (CAT-8015, HA22) in Children With B-lineage Acute Lymphoblastic Leukemia and Minimal Residual Disease Prior to Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions treatment 2 terminated NCT05252403
Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL No drug interventions treatment 2 recruiting NCT02727803
Personalized NK Cell Therapy in CBT No drug interventions treatment 2 recruiting NCT04532203
A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies No drug interventions treatment 0 recruiting NCT02632903
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study No drug interventions treatment 2 withdrawn NCT00402090
DHPLC Determination of TPMT Polymorphisms. No drug interventions Not Available Not Available unknown_status NCT02042690
Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients No drug interventions treatment 3 completed NCT02888990
Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT06209190
Safety and Feasibility of TMLI as Conditioning Regimen in Allogeneic Hematopoietic Stem-cell Transplantation No drug interventions treatment Not Available recruiting NCT01483690
A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL No drug interventions treatment 1 / 2 terminated NCT05774990
Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment No drug interventions Not Available Not Available active_not_recruiting NCT00522990
Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias No drug interventions treatment 1 / 2 terminated NCT01001390
The Effects of Ankle Foot Orthoses on Gait Efficiency in Children With Acute Lymphoblastic Leukemia and Foot Drop No drug interventions supportive_care Not Available terminated NCT05694364
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT02669264
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL) No drug interventions treatment 1 terminated NCT00179764
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) No drug interventions treatment Not Available completed NCT00435864
Natural Killer Index From Hematopoietic Stem Cell Graft No drug interventions health_services_research Not Available completed NCT00300664
A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. No drug interventions Not Available 2 / 3 completed NCT03326921
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant No drug interventions treatment 1 suspended NCT02340884
A Pilot RCT of the PRISM Intervention for AYAs With Cancer No drug interventions health_services_research 2 completed NCT04322084
Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL) No drug interventions Not Available Not Available recruiting NCT01564784
A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia No drug interventions treatment 3 completed NCT02257684
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) No drug interventions treatment 2 terminated NCT01466179
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) No drug interventions treatment 2 completed NCT04262843
Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia No drug interventions treatment 2 recruiting NCT05866887
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia No drug interventions supportive_care Not Available completed NCT04191187
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies treatment 2 active_not_recruiting NCT00015587
Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) No drug interventions Not Available Not Available completed NCT03429387
PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia No drug interventions diagnostic Not Available completed NCT05521087
A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias treatment 1 withdrawn NCT04195633
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies treatment 2 recruiting NCT04606433
Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia No drug interventions treatment 1 recruiting NCT00593554
Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies treatment 2 terminated NCT04340154
Study of Sequential CAR-T Cell Treating Leukemia Children No drug interventions treatment 2 active_not_recruiting NCT02999854
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer prevention 3 terminated NCT01051154
Effect of Enteral Docosahexaenoic Acid Administration in Children With Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT04364451
Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase. No drug interventions Not Available Not Available unknown_status NCT01886651
The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT04008251
Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies No drug interventions treatment 1 unknown_status NCT06242353
Coagulopathy in Childhood Acute Lymphoblastic Leukaemia No drug interventions Not Available Not Available not_yet_recruiting NCT01358253
Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia treatment 4 completed NCT02231853
Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections No drug interventions prevention 1 terminated NCT00131053
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) treatment 2 unknown_status NCT03016377
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL treatment 1 / 2 recruiting NCT03765177
CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies No drug interventions treatment 1 / 2 recruiting NCT01621477
T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant treatment 2 terminated NCT00144677
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation prevention 2 completed NCT00600977
Liposomal Anthracyclin in the Treatment of Elderly ALL treatment 2 completed NCT01523977
Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL treatment 1 completed NCT00807677
A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies treatment 1 completed NCT01565447
Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study No drug interventions Not Available Not Available completed NCT02799147
GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia treatment 1 / 2 completed NCT04732845
Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies treatment 1 recruiting NCT03581045
Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals No drug interventions Not Available Not Available completed NCT05811845
Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL No drug interventions Not Available Not Available recruiting NCT05563545
Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia No drug interventions treatment 1 completed NCT03655145
HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation No drug interventions treatment 3 unknown_status NCT00916045
Pilot Study of Unrelated Cord Blood Transplantation treatment 2 terminated NCT00905398
Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia treatment 1 / 2 terminated NCT01366898
Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years) treatment 4 unknown_status NCT01188798
Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies treatment 3 completed NCT01611298
Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR prevention Not Available completed NCT00187005
Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia treatment 3 terminated NCT05031897
Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant treatment 2 recruiting NCT00187083
A Study of Children With Refractory or Relapsed ALL treatment 3 completed NCT02779283
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia treatment 1 completed NCT02807883
Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia treatment 2 completed NCT01266083
WT-1 Analog Peptide Vaccine in Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL) No drug interventions treatment 2 completed NCT03441061
Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease treatment 2 recruiting NCT02300961
Feasibility Neurocognitive Outcome After Transplant No drug interventions supportive_care Not Available recruiting NCT06446661
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Young Adults With Acute Lymphoblastic Leukemia No drug interventions other Not Available not_yet_recruiting NCT00003861
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia No drug interventions Not Available Not Available active_not_recruiting NCT04817761
SPARK-ALL: Calaspargase Pegol in Adults With ALL treatment 2 / 3 recruiting NCT00096161
Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant treatment 2 completed NCT01015261
Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients No drug interventions treatment 2 / 3 completed NCT00983528
Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia treatment 1 / 2 terminated NCT03911128
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia No drug interventions Not Available Not Available recruiting NCT03118128
Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia basic_science Not Available completed NCT01363128
Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma treatment 2 completed NCT01186328
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) treatment 1 terminated NCT00579111
Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) treatment 1 / 2 terminated NCT00658411
Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation prevention Not Available terminated NCT01300611
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation supportive_care 1 terminated NCT06277011
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research No drug interventions treatment 0 recruiting NCT03331211
Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia Not Available Not Available unknown_status NCT02007811
Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination No drug interventions treatment 1 / 2 unknown_status NCT04473911
Haplo Peripheral Blood Sct In GVHD Prevention treatment 1 active_not_recruiting NCT00557193
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia treatment 3 completed NCT03275493
CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia No drug interventions treatment 1 / 2 recruiting NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL treatment 2 recruiting NCT04537871
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study No drug interventions Not Available Not Available recruiting NCT02181478
Intra-Osseous Co-Transplant of UCB and hMSC treatment 0 completed NCT03564678
Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia supportive_care 2 recruiting NCT02047578
Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL. treatment 2 recruiting NCT03622788
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant treatment 1 / 2 recruiting NCT00719888
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease treatment 2 active_not_recruiting NCT01641107
Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia. treatment 2 completed NCT01089907
Genomic Changes in Childhood Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available unknown_status NCT03705507
International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia treatment 1 / 2 terminated NCT01873807
HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL treatment 4 unknown_status NCT04154709
CTA101 UCAR-T Cell Injection for Treatment of Relapsed or Refractory CD19+ B-cell Acute Lymphoblastic Leukemia No drug interventions treatment 1 unknown_status NCT03798509
Human CD19 Targeted T Cells Injection Therapy for Relapsed and Refractory CD19-positive Leukemia No drug interventions treatment 1 unknown_status NCT00526409
LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia treatment 4 completed NCT00720109
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia treatment 2 / 3 completed NCT00890656
Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage treatment 2 completed NCT05457556
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome treatment 3 recruiting NCT00795756
Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia treatment 2 / 3 completed NCT00961285
Genotyping Analysis of Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available unknown_status NCT01158885
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia treatment 2 terminated NCT00103285
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia treatment 3 completed NCT01149915
Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias treatment 1 completed NCT02256137
A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04327037
Safety of Expanded Haploidentical Natural Killer Cells for Leukemia treatment 1 completed NCT04488237
Vitamin D and Methotrexate Adverse Effects Not Available Not Available unknown_status NCT00346632
An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia No drug interventions treatment 1 terminated NCT05687032
A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia treatment 4 active_not_recruiting NCT01503632
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission supportive_care 3 active_not_recruiting NCT02290132
ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors Not Available Not Available unknown_status NCT05579132
A Phase Ib/II Study of CN201 in Precursor B-cell Acute Lymphoblastic Leukemia treatment 1 / 2 recruiting NCT02862652
Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children. No drug interventions basic_science Not Available completed NCT05657652
CAV Regimen for R/R Ph- B-ALL treatment Not Available recruiting NCT01688752
Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available withdrawn NCT02393859
Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL) treatment 3 completed NCT03913559
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia treatment 2 recruiting NCT03964259
Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia No drug interventions supportive_care 1 completed NCT00526175
LAL-BR/2001: Study Treatment to Low Risk ALL treatment 4 completed NCT00513175
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia No drug interventions Not Available Not Available completed NCT04762875
MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies treatment 2 terminated NCT03803670
Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT05968170
TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant No drug interventions treatment Not Available not_yet_recruiting NCT03318770
Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Not Available Not Available recruiting NCT06128070
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome prevention 2 recruiting NCT00923442
Biology Studies of Hematologic Cancers No drug interventions Not Available Not Available enrolling_by_invitation NCT01976442
Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia No drug interventions Not Available Not Available completed NCT01015742
Unrelated Double Umbilical Cord Blood Units Transplantation No drug interventions treatment 2 / 3 unknown_status NCT00723099
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer treatment 2 completed NCT01794299
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor No drug interventions prevention 2 completed NCT05501899
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia supportive_care 0 recruiting NCT03190499
Quality of Life in Children With Cancer No drug interventions Not Available Not Available completed NCT06125106
Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab treatment 1 recruiting NCT03246906
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation treatment 2 active_not_recruiting NCT06144606
Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) treatment 2 recruiting NCT01393249
PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL No drug interventions Not Available Not Available completed NCT00171249
An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia treatment 2 completed NCT00902213
Physical Activity to Modify Sequelae and Quality of Life in Childhood Acute Lymphoblastic Leukemia No drug interventions treatment Not Available completed NCT01196013
A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia treatment 1 completed NCT04067518
A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia treatment 2 completed NCT00349518
Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL treatment 2 / 3 withdrawn NCT01756118
A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia treatment 1 completed NCT00411541
Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia treatment 4 completed NCT04888741
Methods of T Cell Depletion Trial (MoTD) prevention 2 recruiting NCT05618041
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies No drug interventions treatment Not Available recruiting NCT00184041
Intensified Post Remission Therapy Containing PEG-Asparaginase treatment 2 completed NCT00505141
Urban Environmental Exposures and Childhood Cancer No drug interventions Not Available Not Available completed NCT03178617
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma No drug interventions supportive_care Not Available active_not_recruiting NCT01200017
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant No drug interventions Not Available Not Available no_longer_available NCT05776134
Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel Not Available Not Available available NCT00378534
Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants treatment 2 completed NCT03366324
Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT02118324
Exergaming Intervention in ALL Patients No drug interventions supportive_care Not Available completed NCT05326516
A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia treatment 1 completed NCT00606216
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy No drug interventions Not Available Not Available completed NCT03204916
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available active_not_recruiting NCT03856216
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation treatment 2 recruiting NCT03471416
Nutritional Status in Children With ALL in Guatemala No drug interventions Not Available Not Available completed NCT05589896
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies No drug interventions treatment 1 / 2 recruiting NCT03970096
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) treatment 2 recruiting NCT03677596
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients treatment 4 completed NCT01217996
Computerized Intervention for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors No drug interventions treatment Not Available completed NCT00048958
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma No drug interventions Not Available Not Available active_not_recruiting NCT00241358
Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies treatment 1 / 2 completed NCT02890758
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 treatment 1 completed NCT06393335
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research No drug interventions treatment 0 recruiting NCT04845035
Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia treatment 2 withdrawn NCT06195735
Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALL No drug interventions Not Available Not Available completed NCT01517035
Improving Blood Stem Cell Collection and Transplant Procedures No drug interventions treatment 1 / 2 completed NCT04787263
CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML No drug interventions treatment 1 / 2 recruiting NCT01364363
Unrelated Donor Stem Cell Transplantation No drug interventions treatment Not Available completed NCT05223686
To Evaluate the Safety and Tolerability of Human CD19-CD22 Targeted T Cells Injection for Subjects With R/R B-ALL. No drug interventions treatment 1 not_yet_recruiting NCT00795886
Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL) treatment 2 completed NCT04082286
Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia No drug interventions treatment 1 completed NCT03267186
Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant treatment 2 completed NCT01556386
Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT03333486
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer treatment 2 active_not_recruiting NCT00514722
Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies No drug interventions treatment Not Available terminated NCT05400122
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer treatment 1 recruiting NCT02003222
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia treatment 3 active_not_recruiting NCT04329325
Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia treatment 2 active_not_recruiting NCT00659425
CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma treatment 1 completed NCT00552825
Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children No drug interventions Not Available Not Available completed NCT04629430
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT No drug interventions treatment Not Available completed NCT02847130
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology No drug interventions Not Available Not Available completed NCT05153330
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL No drug interventions treatment 1 recruiting NCT03434730
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation treatment 2 active_not_recruiting NCT01190930
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma treatment 3 active_not_recruiting NCT04105530
Transcranial Direct Current Stimulation of the Temporal Cortex in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) No drug interventions supportive_care Not Available active_not_recruiting NCT04942730
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) treatment 2 completed NCT05581030
CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) treatment 1 recruiting NCT05168748
CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia No drug interventions treatment 1 withdrawn NCT03844048
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial treatment 3 active_not_recruiting NCT00549848
Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia treatment 3 completed NCT06533748
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma treatment 2 not_yet_recruiting NCT04323657
TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia treatment 1 / 2 completed NCT01700751
Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation treatment 1 completed NCT00718757
Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies treatment 1 completed NCT01095926
Pharmacokinetic Study of Doxorubicin in Children With Cancer treatment 2 completed NCT03114865
A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance treatment 1 / 2 active_not_recruiting NCT03147365
Effect of Different Exercises on Quality of Life of Leukemia Patients. No drug interventions other Not Available completed NCT04282174
CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies treatment 2 withdrawn NCT05410574
Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic Leukemia No drug interventions supportive_care Not Available terminated NCT02451774
Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction treatment 2 / 3 unknown_status NCT03314974
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders No drug interventions treatment 2 recruiting NCT00439920
GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL. No drug interventions treatment 2 unknown_status NCT06338020
Adaptive Variable-Resistance Training in Pediatric Survivors of Acute Lymphoblastic Leukemia No drug interventions treatment Not Available completed NCT00957320
Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL) treatment 1 withdrawn NCT01045382
MSC and HSC Coinfusion in Mismatched Minitransplants No drug interventions treatment 2 terminated NCT01761682
Acute Lymphoblastic Leukemia Registry at Asan Medical Center No drug interventions Not Available Not Available terminated NCT06025682
Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO No drug interventions Not Available Not Available recruiting NCT04015882
Effects of Exercises on Total Body Health in Children With Acute Lymphoblastic Leukemia No drug interventions supportive_care Not Available completed NCT01471782
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia treatment 1 / 2 completed NCT05587582
Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication Adherence No drug interventions Not Available Not Available recruiting NCT01424982
Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia treatment 2 active_not_recruiting NCT01713582
A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001) treatment 1 completed NCT00192673
Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses treatment 4 unknown_status NCT03399773
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes treatment 2 recruiting NCT02264873
Phase I, Dose Escalation Study of Decitabine treatment 1 completed NCT06289673
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma treatment 4 not_yet_recruiting NCT01110473
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies treatment 1 completed NCT01142427
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT05739227
Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies No drug interventions treatment 0 recruiting NCT00131027
High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) treatment 3 unknown_status NCT05386576
A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) treatment 0 active_not_recruiting NCT04225676
Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL) treatment 2 terminated NCT01207076
AHN-12 Biodistribution in Advanced Leukemia No drug interventions treatment 1 terminated NCT05929976
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort No drug interventions Not Available Not Available recruiting NCT00789776
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer treatment 1 / 2 completed NCT02912676
Thiopurine EnhAnced Maintenance Therapy treatment 1 / 2 completed NCT05428176
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT02186860
Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphoblastic Leukemia No drug interventions treatment 1 unknown_status NCT00460694
Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies No drug interventions treatment 1 / 2 completed NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia treatment 3 recruiting NCT03187691
Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia prevention 2 withdrawn NCT06195891
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome treatment 1 recruiting NCT06461091
the Efficacy and Safety of Total Myeloid Irradiation (TMI) in the Treatment of Adult Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available not_yet_recruiting NCT03594162
Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch Not Available Not Available no_longer_available NCT06299462
PTCy and ATG for MSD and MUD Transplants prevention 1 / 2 recruiting NCT05364762
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants prevention 2 recruiting NCT01663129
Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study No drug interventions Not Available Not Available completed NCT05515029
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis treatment 3 active_not_recruiting NCT02544789
Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia treatment 2 completed NCT00391989
Treatment of Adult Ph+ LAL With BMS-354825 treatment 2 completed NCT03005392
Home-exercise Program for Children and Adolescent Survivors of Acute Lymphoblastic Leukemia No drug interventions treatment 1 / 2 completed NCT05918692
A Phase 1, Study of BMF-500 in Adults With Acute Leukemia No drug interventions treatment 1 recruiting NCT03982992
Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab treatment 2 withdrawn NCT04209244
Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia No drug interventions prevention Not Available recruiting NCT06323044
MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence No drug interventions supportive_care Not Available not_yet_recruiting NCT03860844
Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia treatment 2 terminated NCT05321940
Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias No drug interventions treatment 1 withdrawn NCT01457040
Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia No drug interventions treatment 2 / 3 completed NCT05887167
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies No drug interventions treatment 1 recruiting NCT05306301
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients treatment 2 recruiting NCT04007601
Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) No drug interventions supportive_care Not Available completed NCT00186901
A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors treatment 3 completed NCT04814004
Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors No drug interventions treatment 1 unknown_status NCT04689204
A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies No drug interventions treatment 0 recruiting NCT02228772
Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults treatment 1 completed NCT00576472
Learning Impairments Among Survivors of Childhood Cancer supportive_care 4 completed NCT03301168
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant treatment 1 / 2 active_not_recruiting NCT02744768
D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia treatment 2 unknown_status NCT04888468
Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents No drug interventions treatment 1 completed NCT04532268
A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL No drug interventions treatment 0 recruiting NCT03494569
Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome treatment 1 recruiting NCT02065869
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant treatment 1 / 2 terminated NCT00723346
Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia treatment 1 / 2 completed NCT01169012
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias basic_science 1 completed NCT03147612
Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia treatment 2 active_not_recruiting NCT02315612
Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies No drug interventions treatment 1 active_not_recruiting NCT01231412
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant treatment 3 completed NCT05800210
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases No drug interventions treatment 2 recruiting NCT01187810
Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL treatment 1 terminated NCT03821610
A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC) treatment 2 active_not_recruiting NCT02580981
Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses No drug interventions treatment Not Available terminated NCT06527781
A Study of PD5K3 in Healthy Adult Volunteers treatment 1 completed NCT06392581
Observational Study on Invasive Fungal Infection Incidence in Ph-neg Acute Lymphoblastic Leukemia Patients No drug interventions Not Available Not Available recruiting NCT02185781
Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL) No drug interventions treatment 1 completed NCT00270881
Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies treatment 1 / 2 completed NCT06101381
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma treatment 1 / 2 not_yet_recruiting NCT00388895
Glivec in Ph Positive Lymphoblastic Leukemia treatment 2 completed NCT03802695
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies No drug interventions treatment 1 recruiting NCT01014195
Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors No drug interventions Not Available Not Available completed NCT00466895
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia. treatment 1 completed NCT00130195
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) treatment 2 completed NCT00368355
T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts treatment 2 completed NCT05535855
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1 No drug interventions treatment 1 recruiting NCT00898755
Collecting and Storing Tissue From Young Patients With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04975555
Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy treatment 2 recruiting NCT00458250
Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H treatment 1 completed NCT02500550
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor prevention 2 completed NCT02339350
Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children treatment 2 unknown_status NCT02435550
iCare for Cancer Patients No drug interventions diagnostic Not Available terminated NCT04843150
Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot Study No drug interventions Not Available Not Available completed NCT02197650
Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase Not Available Not Available no_longer_available NCT02810223
Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia treatment 1 unknown_status NCT06013423
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases treatment 2 recruiting NCT05334823
A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents No drug interventions treatment 2 recruiting NCT02070523
Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia: No drug interventions treatment 3 unknown_status NCT01744223
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant treatment 1 / 2 active_not_recruiting NCT03627208
Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch No drug interventions Not Available Not Available completed NCT01643408
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy treatment 2 completed NCT00853008
Treatment of High Risk Adult Acute Lymphoblastic Leukemia treatment 4 completed NCT01678508
Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT02508038
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors treatment 1 recruiting NCT01297543
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia supportive_care 1 / 2 completed NCT02879643
Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL treatment 1 unknown_status NCT02310243
Study of Palbociclib in MLL-rearranged Acute Leukemias treatment 1 / 2 unknown_status NCT00412243
Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients treatment 1 / 2 completed NCT00846703
The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia treatment 4 unknown_status NCT05268003
A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia treatment 2 recruiting NCT01513603
Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia treatment 2 unknown_status NCT03932903
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia No drug interventions supportive_care Not Available not_yet_recruiting NCT00144703
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation prevention 2 completed NCT01494103
Administration of Donor T Cells With the Caspase-9 Suicide Gene treatment 1 active_not_recruiting NCT05763290
Childhood Cancer Survivors' Affective Response to Exercise No drug interventions Not Available Not Available recruiting NCT02188290
Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation No drug interventions Not Available Not Available completed NCT00476190
ALL Adult Consortium Trial: Adult ALL Trial treatment 2 active_not_recruiting NCT02670564
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) No drug interventions basic_science 4 recruiting NCT02535364
Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL) treatment 2 terminated NCT04014764
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy No drug interventions Not Available Not Available completed NCT00968864
T-cell Depleted Alternative Donor Transplantation No drug interventions treatment 2 terminated NCT03571321
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia treatment 1 recruiting NCT01685021
Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL) treatment 2 terminated NCT00693602
Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma supportive_care 1 completed NCT05969002
Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias No drug interventions Not Available Not Available recruiting NCT05326984
Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia basic_science Not Available unknown_status NCT04635384
Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test No drug interventions Not Available Not Available recruiting NCT02373579
Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia supportive_care 2 completed NCT00619879
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies No drug interventions treatment 3 unknown_status NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT05519579
Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia prevention 2 recruiting NCT00861679
Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International No drug interventions treatment Not Available completed NCT02872987
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial No drug interventions Not Available Not Available recruiting NCT01380587
Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00165087
Treatment of Childhood Acute Lymphoblastic Leukemia treatment 3 terminated NCT05064787
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy No drug interventions supportive_care Not Available completed NCT06220487
A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL treatment 2 recruiting NCT03272633
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies No drug interventions treatment 0 terminated NCT00374933
Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation No drug interventions treatment 1 completed NCT02716233
A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents treatment 3 recruiting NCT03779854
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant treatment 2 recruiting NCT00819351
ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase treatment 3 completed NCT03117751
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma treatment 2 / 3 active_not_recruiting NCT02743351
Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies No drug interventions prevention 1 / 2 completed NCT02369653
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase prevention 3 completed NCT03628053
Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia treatment 3 withdrawn NCT01506453
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL) supportive_care 2 completed NCT01462253
Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults treatment 2 completed NCT02888977
Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL No drug interventions Not Available Not Available unknown_status NCT03187977
Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI No drug interventions supportive_care Not Available completed NCT05972577
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study No drug interventions supportive_care Not Available active_not_recruiting NCT04060277
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation supportive_care 2 active_not_recruiting NCT03007147
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia treatment 3 active_not_recruiting NCT00719147
AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone No drug interventions Not Available Not Available completed NCT00900445
Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia Not Available Not Available withdrawn NCT03278145
Dependence Receptors and Leukemia No drug interventions Not Available Not Available unknown_status NCT00930098
A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia treatment 2 completed NCT03141398
Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group No drug interventions Not Available Not Available withdrawn NCT01256398
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia treatment 2 completed NCT02991898
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies No drug interventions treatment 2 terminated NCT00287105
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children treatment 2 completed NCT00682305
Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL) No drug interventions treatment 2 completed NCT00315705
A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. treatment 1 / 2 completed NCT00526305
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive treatment 4 completed NCT00494897
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia treatment 4 completed NCT01004497
First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL treatment 2 completed NCT03902197
CD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL Patients No drug interventions treatment 2 unknown_status NCT04049383
CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL No drug interventions treatment 1 recruiting NCT01696461
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor treatment 2 completed NCT03898128
ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate No drug interventions Not Available Not Available unknown_status NCT01159028
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS treatment 1 completed NCT01910428
L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL treatment 1 terminated NCT01326728
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available terminated NCT03298828
CD19 CAR and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma No drug interventions treatment 1 unknown_status NCT00945828
Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors No drug interventions supportive_care Not Available completed NCT06291428
Raman Spectroscopy Compared to Flow Cytometry No drug interventions Not Available Not Available not_yet_recruiting NCT01685411
Busulfan and Cyclophosphamide Followed By ALLO BMT treatment Not Available terminated NCT04158011
A Retrospective Study of Patients With Leukemia Relapse in the CNS Treated With CAR T Cells No drug interventions Not Available Not Available unknown_status NCT00137111
Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia treatment 3 completed NCT00766311
Aerobic and Strengthening Exercise for Acute Leukemia No drug interventions supportive_care Not Available completed NCT00388193
Rituximab Combined With Chemotherapy in Burkitt's Lymphoma treatment 2 completed NCT03448393
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies treatment 1 recruiting NCT00390793
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. treatment 2 completed NCT01906671
Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid treatment 4 unknown_status NCT00697671
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies treatment 1 completed NCT05963971
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors No drug interventions prevention Not Available recruiting NCT01795378
Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation treatment 1 / 2 completed NCT02349178
Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT treatment 2 terminated NCT00165178
Treatment of Acute Lymphoblastic Leukemia in Children treatment 3 completed NCT01025778
Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia treatment 2 completed NCT04007978
Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell Malignancies No drug interventions treatment 1 unknown_status NCT05578378
Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL treatment 2 / 3 recruiting NCT04872478
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL No drug interventions treatment 1 recruiting NCT01593488
Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children treatment 2 active_not_recruiting NCT01230788
Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia treatment Not Available terminated NCT04796688
Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies treatment 1 unknown_status NCT04168788
Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL No drug interventions basic_science Not Available unknown_status NCT04904588
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide treatment 2 recruiting NCT06308588
Phase II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia treatment 2 recruiting NCT00866307
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) treatment 1 completed NCT02475707
Administration of Donor MultiTAA-Specific T Cells for ALL No drug interventions treatment 1 active_not_recruiting NCT01079507
Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available unknown_status NCT01036009
A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies No drug interventions treatment 2 completed NCT05440409
CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL No drug interventions Not Available Not Available active_not_recruiting NCT00686556
Total Marrow Irradiation for Refractory Acute Leukemia treatment 1 completed NCT03887156
Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft No drug interventions diagnostic 2 / 3 unknown_status NCT00539656
Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers No drug interventions treatment 1 / 2 terminated NCT01184885
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy treatment 0 completed NCT01951885
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention supportive_care 3 completed NCT06001385
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis treatment 2 recruiting NCT04227015
A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy No drug interventions treatment 0 recruiting NCT06160115
The Role of NK Cells to Detect Blood Infection in ALL. No drug interventions Not Available Not Available not_yet_recruiting NCT05442515
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies treatment 1 / 2 recruiting NCT00590915
Erwinase Master Treatment Protocol Not Available Not Available no_longer_available NCT00995137
Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia No drug interventions treatment 1 completed NCT00328237
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation No drug interventions treatment 2 unknown_status NCT00774332
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL No drug interventions treatment 2 unknown_status NCT05433532
Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients treatment 2 completed NCT06452732
Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML No drug interventions Not Available Not Available not_yet_recruiting NCT04943952
JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase Not Available Not Available approved_for_marketing NCT02813252
Long-Term Follow-up Study for Patients Previously Treated With JCAR015 No drug interventions Not Available Not Available completed NCT00973752
Treatment of Older Adults With Acute Lymphoblastic Leukemia treatment 2 completed NCT05772000
Clinical Significance of Occult Central Nervous System Localization No drug interventions Not Available Not Available recruiting NCT00750659
Nilotinib Pre and Post Allogeneic Stem Cell Transplantation treatment 2 completed NCT00143559
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies No drug interventions treatment 2 completed NCT00285259
Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) No drug interventions treatment 2 completed NCT00276159
Study of Immune Response Modifier in the Treatment of Hematologic Malignancies No drug interventions treatment 2 terminated NCT02639559
Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies treatment 2 completed NCT02815059
Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone treatment 1 withdrawn NCT00678275
Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia No drug interventions treatment 3 completed NCT00186875
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia treatment 2 completed NCT01134575
CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) treatment 2 completed NCT01139970
Veliparib and Temozolomide in Treating Patients With Acute Leukemia treatment 1 active_not_recruiting NCT04083170
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers treatment 2 terminated NCT00961142
Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia treatment 2 terminated NCT04065399
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation treatment 1 / 2 recruiting NCT04928599
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States No drug interventions Not Available Not Available suspended NCT06508099
Vitamin A and D Supplementation in Allogeneic HCT treatment 2 recruiting NCT02535806
Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults treatment 2 terminated NCT04151706
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML treatment 2 completed NCT00816049
ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy treatment 3 completed NCT03733249
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study treatment 1 / 2 terminated NCT00990249
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation treatment 2 completed NCT06477549
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT treatment 2 recruiting NCT01677949
Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia treatment 2 withdrawn NCT01324336
Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets Not Available Not Available completed NCT03249636
New Markers for Minimal Residual Disease in Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available unknown_status NCT03920813
Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy treatment 4 unknown_status NCT02529813
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies treatment 1 completed NCT00798213
SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED) treatment 2 terminated NCT04764513
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT No drug interventions treatment 1 / 2 recruiting NCT01312818
Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) treatment 2 terminated NCT02447718
Vaccinating Children After Chemotherapy prevention 4 completed NCT00513318
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies No drug interventions Not Available Not Available terminated NCT06087419
A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients treatment 1 / 2 not_yet_recruiting NCT03318419
Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia treatment 2 unknown_status NCT05326919
The Patient Cohort of the National Center for Precision Medicine in Leukemia No drug interventions Not Available Not Available recruiting NCT00862719
Sitagliptin Umbilical Cord Blood Transplant Study treatment 2 completed NCT01307241
RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML No drug interventions Not Available Not Available unknown_status NCT05541341
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies No drug interventions Not Available Not Available recruiting NCT04726241
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study No drug interventions screening 1 / 2 recruiting NCT01439217
Endothelial Function, Arterial Stiffness and Components No drug interventions Not Available Not Available completed NCT00784017
Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia treatment 3 completed NCT05375617
European Prospective Investigation Into Childhood Cancer No drug interventions Not Available Not Available recruiting NCT05735717
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies treatment 2 recruiting NCT05679817
How Effective is the Dose-graded Aerobic Training in Children Survivors of Acute Lymphoblastic Leukemia? No drug interventions treatment Not Available completed NCT06093334
Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD No drug interventions diagnostic Not Available recruiting NCT03904134
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) No drug interventions treatment Not Available active_not_recruiting NCT01148134
Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALL No drug interventions Not Available Not Available terminated NCT03286634
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 treatment 2 recruiting NCT00726934
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients No drug interventions supportive_care Not Available completed NCT00671034
Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia treatment 3 completed NCT00602134
Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions treatment Not Available completed NCT03128034
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia treatment 1 / 2 suspended NCT01470924
Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007 No drug interventions Not Available Not Available completed NCT00940524
Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia treatment 1 completed NCT01104324
Osteonecrosis in Children With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available unknown_status NCT03533816
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide treatment 1 recruiting NCT06575296
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant treatment 1 not_yet_recruiting NCT00439296
ABT-751 With Chemotherapy for Relapsed Pediatric ALL treatment 1 / 2 terminated NCT03810196
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT No drug interventions treatment Not Available recruiting NCT04095858
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005) treatment 3 terminated NCT01100658
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors treatment Not Available terminated NCT00671658
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia treatment 2 completed NCT00136435
A Study in Adults With Untreated Acute Lymphoblastic Leukemia treatment 2 active_not_recruiting NCT01532635
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives treatment 2 terminated NCT00144963
Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia treatment 1 / 2 completed NCT05793463
Anti-mullerian Hormone in Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available recruiting NCT04684563
huCART19-IL18 in NHL/CLL Patients No drug interventions treatment 1 recruiting NCT00859586
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation No drug interventions treatment Not Available completed NCT02881086
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment treatment 3 active_not_recruiting NCT03123939
Phase III B in Acute Lymphoblastic Leukemia treatment 3 completed NCT02646839
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children No drug interventions treatment 2 enrolling_by_invitation NCT03027739
CART-19 Cells For MRD Positive CD19+ ALL treatment 2 / 3 unknown_status NCT03476239
Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) treatment 3 completed NCT02295839
Sleep Hygiene and Relaxation Intervention to Improve Sleep and Fatigue for Children Receiving Maintenance Chemotherapy No drug interventions supportive_care Not Available completed NCT00075725
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia treatment 3 completed NCT00967525
Intraosseous Infusion of Unrelated Cord Blood Grafts No drug interventions treatment Not Available terminated NCT06367725
Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density No drug interventions Not Available Not Available recruiting NCT04666025
SARS-CoV-2 Donor-Recipient Immunity Transfer No drug interventions Not Available Not Available completed NCT03575325
Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia treatment 2 completed NCT02360930
Vincristine PK and PD in the AYA Population Compared to Younger Children No drug interventions Not Available Not Available unknown_status NCT03267030
Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase treatment 2 completed NCT00114348
ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia No drug interventions treatment 4 completed NCT04825548
Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol No drug interventions Not Available Not Available completed NCT00792948
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia treatment 2 active_not_recruiting NCT04187248
The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008 Not Available Not Available completed NCT04092348
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available not_yet_recruiting NCT01354457
Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+ treatment 1 / 2 unknown_status NCT06227026
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies No drug interventions treatment 1 recruiting NCT03642626
MT2017-45: CAR-T Cell Therapy for Heme Malignancies Not Available Not Available active_not_recruiting NCT04954326
A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL) treatment 2 completed NCT00440726
Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) treatment 1 / 2 completed NCT03919526
Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALL treatment 1 completed NCT04956666
A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL) No drug interventions treatment 2 completed NCT01119066
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies treatment 2 completed NCT02099266
Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment No drug interventions treatment Not Available completed NCT00911066
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia treatment 1 completed NCT03568266
Pharmacogenomics of Asparaginase Induced Hepatotoxicity No drug interventions Not Available Not Available recruiting NCT05014165
Backtracking Leukemia-Typical Somatic Mutations in Cord Blood No drug interventions Not Available Not Available recruiting NCT05054465
A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL treatment 1 / 2 not_yet_recruiting NCT01574274
SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma treatment 2 active_not_recruiting NCT05025774
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise No drug interventions Not Available Not Available not_yet_recruiting NCT01697020
Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions treatment 1 completed NCT06475820
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis treatment 2 / 3 active_not_recruiting NCT02404220
Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) treatment 1 / 2 terminated NCT01253720
PACE CALL: Weight Loss Study for Childhood Leukemia Survivors No drug interventions prevention Not Available completed NCT00954720
Observational Study of Iron Overload in Stem Cell Transplantation No drug interventions Not Available Not Available completed NCT01810120
Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT No drug interventions treatment 1 / 2 completed NCT01047020
Motor Proficiency And Physical Activity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) No drug interventions Not Available Not Available completed NCT03096782
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma treatment 2 completed NCT02336282
Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia No drug interventions supportive_care Not Available completed NCT01523782
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia treatment 2 completed NCT01943682
Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma No drug interventions treatment 1 completed NCT02494882
Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older treatment 1 active_not_recruiting NCT04677231
Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired Protocol No drug interventions Not Available Not Available unknown_status NCT02443831
CARPALL: Immunotherapy With CD19/22 CAR T-cells for CD19+ Haematological Malignancies treatment 1 active_not_recruiting NCT00664131
Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors No drug interventions Not Available Not Available completed NCT04145531
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) treatment 2 / 3 completed NCT02010931
Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients No drug interventions Not Available Not Available completed NCT03422731
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy diagnostic 0 recruiting NCT05639673
Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available recruiting NCT02996773
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine treatment 1 active_not_recruiting NCT00964873
A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia treatment 1 completed NCT01279473
Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study) treatment 1 / 2 completed NCT02272673
The Effects of Honey on Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT02086773
Red Cell Transfusion Goals in Patients With Acute Leukemias No drug interventions supportive_care 1 completed NCT03235973
Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes treatment 1 unknown_status NCT00222027
Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial No drug interventions treatment 2 completed NCT01148927
Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00674427
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant No drug interventions treatment 1 terminated NCT04307576
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia treatment 3 recruiting NCT02553460
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I treatment 1 / 2 active_not_recruiting NCT04811560
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia treatment 1 / 2 recruiting NCT00529360
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL treatment 1 / 2 completed NCT00560794
Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) treatment 2 completed NCT06350994
Early Assessment of Cardiac Function After Treatment With CAR-T Cells No drug interventions Not Available Not Available not_yet_recruiting NCT06408194
Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies treatment 1 recruiting NCT05621291
A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu... No drug interventions diagnostic Not Available recruiting NCT06059391
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant treatment 2 recruiting NCT04699162
Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT01476462
Second Malignant Neoplasms After Childhood ALL Therapy No drug interventions Not Available Not Available completed NCT00874562
Rapamycin in Relapsed Acute Lymphoblastic Leukemia Not Available 1 completed NCT01324180
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) treatment 1 completed NCT00026780
Eligibility Screening for a NCI Pediatric Oncology Branch Research Study No drug interventions Not Available Not Available completed NCT01195480
CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL) No drug interventions treatment 1 / 2 terminated NCT00475280
"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients No drug interventions treatment 2 completed NCT04179929
Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults No drug interventions treatment Not Available recruiting NCT04226989
A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy No drug interventions treatment 0 unknown_status NCT02965092
CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT03668392
Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL) treatment 2 terminated NCT01094392
Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL) No drug interventions Not Available Not Available completed NCT02588092
Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL) treatment 1 terminated NCT00710892
CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene No drug interventions treatment 1 active_not_recruiting NCT00991744
Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL) treatment 3 suspended NCT06287944
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome treatment 1 not_yet_recruiting NCT01077544
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL) treatment 1 completed NCT05751044
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies treatment 1 / 2 not_yet_recruiting NCT03960840
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, ALL and 1L HR LBCL treatment 1 / 2 recruiting NCT01854567
P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies No drug interventions treatment 3 completed NCT05809167
Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT No drug interventions treatment 2 recruiting NCT04340167
Study of Anti-CD22 CAR-T Cells Treating Leukemia Children No drug interventions treatment 2 recruiting NCT00376467
STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia treatment 2 completed NCT01068301
A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation treatment 1 completed NCT01358201
PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years treatment 4 unknown_status NCT04969601
Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings prevention 1 / 2 completed NCT03226704
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing No drug interventions Not Available Not Available enrolling_by_invitation NCT04452604
Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19 No drug interventions Not Available Not Available completed NCT05950204
Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia. No drug interventions supportive_care Not Available recruiting NCT01766804
Effect of Bovine Colostrum on Toxicity and Inflammatory Responses No drug interventions treatment Not Available completed NCT05139004
90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome No drug interventions treatment 1 recruiting NCT00358072
Treatment of Adult ALL With an MRD-directed Programme. No drug interventions treatment 2 completed NCT03263572
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia No drug interventions treatment 2 recruiting NCT01842672
Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia No drug interventions treatment 1 / 2 completed NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01643668
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation No drug interventions treatment 2 completed NCT01044069
Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 No drug interventions treatment 1 active_not_recruiting NCT05334069
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection No drug interventions Not Available Not Available recruiting NCT05037669
Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma No drug interventions treatment 1 withdrawn NCT04233346
The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation No drug interventions treatment 2 active_not_recruiting NCT04096846
Effect of Vitamin D Diffiency on Oral Mucosa in Patients Recieving Methotrexate Chemotherapy No drug interventions Not Available Not Available unknown_status NCT02960646
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies No drug interventions treatment 1 completed NCT03023046
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma No drug interventions treatment 2 completed NCT01540812
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS No drug interventions Not Available Not Available completed NCT02003612
Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00222612
Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 No drug interventions treatment 4 unknown_status NCT04747912
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) No drug interventions treatment 2 recruiting NCT03195010
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia No drug interventions supportive_care 2 terminated NCT00797810
Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults No drug interventions treatment 4 unknown_status NCT03768310
CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA) No drug interventions treatment 1 withdrawn NCT05133310
Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia No drug interventions treatment 4 unknown_status NCT04532281
A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies No drug interventions treatment 0 recruiting NCT04554381
Assesment of JL1 Expression in Acute Leukemia No drug interventions diagnostic 1 unknown_status NCT05381181
Safety and Efficacy Evaluation of Next-generation CD19-UCART No drug interventions treatment 1 not_yet_recruiting NCT00866281
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia No drug interventions treatment 1 / 2 terminated NCT00539695
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD No drug interventions treatment 2 completed NCT02566395
Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies No drug interventions treatment 3 completed NCT00982514
Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008 No drug interventions Not Available Not Available unknown_status NCT04843514
TDM of Asparaginase in ALL2008 No drug interventions Not Available Not Available completed NCT02143414
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia No drug interventions treatment 2 active_not_recruiting NCT03286114
Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab No drug interventions treatment 1 terminated NCT00790855
Bendamustine in Acute Leukemia and MDS No drug interventions treatment 1 / 2 terminated NCT04524455
Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL No drug interventions treatment 1 completed NCT03555955
A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 No drug interventions treatment 1 completed NCT01684150
A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving No drug interventions treatment 1 completed NCT02518750
Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma No drug interventions treatment 2 terminated NCT03366350
Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT03742323
REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic Leukemia No drug interventions treatment 1 / 2 terminated NCT00944008
PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic Leukemia No drug interventions prevention 3 terminated NCT01041508
Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia. No drug interventions treatment 1 completed NCT02544438
Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia No drug interventions treatment 1 / 2 completed NCT00003838
Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow No drug interventions treatment 2 completed NCT02935543
CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL No drug interventions treatment 2 terminated NCT04206943
Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL No drug interventions treatment 1 / 2 unknown_status NCT01486043
Metformin and Transient Hyperglycemia No drug interventions treatment Not Available terminated NCT05068401
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies treatment 1 not_yet_recruiting NCT04976699
CD24Fc for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005) treatment 3 active_not_recruiting NCT06355583
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial No drug interventions prevention 2 not_yet_recruiting NCT01251809
Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia treatment 1 / 2 terminated NCT01334060
WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation No drug interventions treatment 2 completed NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia treatment 2 / 3 recruiting NCT01272440
A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia No drug interventions Not Available Not Available unknown_status NCT03593304
Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients prevention 2 / 3 completed NCT01616238
A Study for Older Adults With Acute Lymphoblastic Leukaemia No drug interventions treatment 2 completed NCT00866671
Observational Study of Nelarabine in Children and Young Adults Not Available Not Available completed NCT06037018
Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies No drug interventions treatment 1 recruiting NCT01597219
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers No drug interventions treatment 2 completed NCT01619124
Osteonecroses in Pediatric Patients With ALL No drug interventions Not Available Not Available unknown_status